共 43 条
[1]
Bruning P.F., Van Doorn J., Bonfrer J.M., Et al., Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer, Int J Cancer, 62, pp. 266-270, (1995)
[2]
Hankinson S.E., Willett W.C., Colditz G.A., Et al., Circulating concentrations of insulin-like growth factor-I and risk of breast cancer, Lancet, 351, pp. 1393-1396, (1998)
[3]
Chan J.M., Stampfer M.J., Giovannucci E., Et al., Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study, Science, 279, pp. 563-566, (1998)
[4]
Wolk A., Mantzoros C.S., Andersson S.O., Et al., Insulinlike growth factor 1 and prostate cancer risk: A population-based, case-control study, J Natl Cancer Inst, 90, pp. 911-915, (1998)
[5]
Manousos O., Souglakos J., Bosetti C., Et al., IGF-I and IGF-II in relation to colorectal cancer, Int J Cancer, 83, pp. 15-17, (1999)
[6]
Ma J., Pollak M.N., Giovannucci E., Et al., Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3, J Natl Cancer Inst, 91, pp. 620-625, (1999)
[7]
Giovannucci E., Pollak M.N., Platz E.A., Et al., A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal cancer in women, Cancer Epidemiol Biomarkers Prev, 9, pp. 345-349, (2000)
[8]
Yu H., Spitz M.R., Mistry J., Gu J., Hong W.K., Wu X., Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis, J Natl Cancer Inst, 91, pp. 151-156, (1999)
[9]
Cohen P., Clemmons D.R., Rosenfeld R.G., Does the GH-IGF axis play a role in cancer pathogenesis?, Growth Horm IGF Res, 10, pp. 297-305, (2000)
[10]
Rosen C.J., Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications, Clin Chem, 45, pp. 1384-1390, (1999)